Stemline Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference

NEXT STORY
DBV Technologies Reports Positive Three-Year, Long-Term Data from the PEOPLE Phase III Open-Label Extension Study of Viaskin Peanut in Children with Peanut Allergy
PREV STORY
Nabriva Therapeutics Receives FDA Acknowledgement of New Drug Application Resubmission for Intravenous CONTEPO™ (fosfomycin) for Injection
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

GeoVax Strengthens Scientific Staff and Expertise

ATLANTA, GA, Aug. 29, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: ...

author_avatar
NASDAQ Market News

Life Foundation Awards $140k to Support Those with Infertility

CHICAGO, Aug. 16, 2016 (GLOBE NEWSWIRE) -- The Kevin J. Lederer Life Foundation announced ...

author_avatar
NASDAQ Market News

Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

BOSTON, June 01, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company ...

author_avatar
NASDAQ Market News